Zion Williamson is ruled OUT of the Pelicans' NBA play
Time:2024-05-01 09:44:52 Source:sportViews(143)
New Orleans Pelicans star Zion Williamson will miss Friday's play-in tournament elimination game against the Sacramento Kings with a left hamstring injury.
Williamson departed with 3:13 remaining after scoring 40 points in a 110-106 loss to the Los Angeles Lakers on Tuesday night in New Orleans.
The Lakers clinched the No. 7 seed in the NBA playoffs, while the Pelicans earned a do-or-die date at home Friday against the Kings.
The winner will grab the No. 8 seed in the Western Conference and will meet the top-seeded Oklahoma City Thunder in the first round.
Williamson had just tied the score at 95-95 on Tuesday when he exited with an injury to his left leg.
Zion Williamson has been ruled out of the Pelicans' NBA play-in game against Sacramento
In addition to his game-high 40 points on 17-of-27 shooting, the two-time All-Star forward added 11 rebounds, five assists, one steal and one block.
It's claimed Williamson, 23, will be evaluated again in the coming weeks.
Williamson averaged 22.9 points, 5.8 rebounds and 5.0 assists in 70 games this season.
The 2019 No. 1 overall draft pick has career averages of 24.7 points, 6.5 boards and 4.1 assists in 184 games.
Previous:Ralph Lauren goes minimal for latest fashion show, with muted tones and a more intimate setting
Next:New Jersey seeks fourth round of offshore wind farm proposals as foes push back
You may also like
- French cops drag pro
- Two Iraqi military bases bombed by unknown aircraft near Baghdad
- Wine to five! Dolly Parton 'planning to launch own range of alcoholic drinks'
- Hawaii is known for its macadamia nuts. Lawmakers want to keep it that way
- Box office: ‘Challengers’ scores with $15 million in ticket sales
- Indonesian and Singaporean leaders hold annual talks, joined this year by their successors
- Edwards and Towns lead Timberwolves into the 2nd round of the NBA playoffs for 1st time since 2004
- Romanian artists share China travel experiences
- The cancer drugs that could improve survival rates if given to patients in the morning